HomeNewsNeuroscienceMigraine

  • TENS could be a new treatment for Migraine, finds study

    • June 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Aimovig for Migraine receives positive CHMP opinion by EMA, might get approved soon in EU

    • June 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Zosano Announces new trial results for its Headache drug

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Confirms September PDUFA Date for Fremanezumab

    • May 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Aimovig, first aCGRP drug for preventive treatment of Migraine

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Announces Publication of Ph III Data of Fremanezumab for the Preventive Treatment of Episodic Migraine

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Lilly’s Galcanezumab Meets Primary Endpoint in Ph 3 Study for Episodic Cluster Headache

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Chronic Migraine Can Be Treated With Trigeminal Nerve Stimulation

    • May 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Allergan’s Ubrogepant registers second Positive Ph 3 Trial results in Migraine

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New data demonstrates Eptinezumab Increased Migraine-Free Intervals and improved Quality-of-Life Outcomes in Episodic Migraine patients

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more